🇺🇸 FDA
Pipeline program

Buprenorphine + naloxone (Suboxone)

BU0808

Approved small_molecule completed

Quick answer

Buprenorphine + naloxone (Suboxone) for Opiate Dependence is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opiate Dependence
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials